Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/4670
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gultekin, F. | - |
dc.contributor.author | Patat, S. | - |
dc.contributor.author | Akça, Hakan | - |
dc.contributor.author | Akdogan, M. | - |
dc.contributor.author | Altuntas, I. | - |
dc.date.accessioned | 2019-08-16T11:36:08Z | |
dc.date.available | 2019-08-16T11:36:08Z | |
dc.date.issued | 2006 | - |
dc.identifier.issn | 0960-3271 | - |
dc.identifier.uri | https://hdl.handle.net/11499/4670 | - |
dc.identifier.uri | https://doi.org/10.1191/0960327106ht584oa | - |
dc.description.abstract | The cytotoxic effect of chlorpyrifos (CP) on human HepG2 cell lines and the protective role of melatonin were investigated. TD50 of CP for HepG2 cells was also determined. The viability of HepG2 cells decreased with CP treatment in a dose-dependent manner (P <0.05). Pre-incubation with melatonin prior to CP application caused an increase in cell viability (P <0.05). TD50 of CP for HepG2 was determined as 84.5 µg/mL. A 1-hour melatonin treatment caused a decrease in TD50 from 84.5 to 34.1 µg/mL. The level of thiobarbituric acid reactive substance (TBARS) and the activities of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and catalase (CAT) were determined in cell lines with or without melatonin administration to find out the possible mechanism of melatonin. CP caused a significant decrease in SOD, GSH-Px and CAT activities and an increase in TBARS level (P <0.05). Pre-incubation of cells with melatonin prevented an increase in TBARS. Melatonin also reduced the CP-caused inhibition of the activities of GSH-Px and CAT (P <0.05). It was suggested that CP shows a cytotoxic effect on HepG2 cell lines and melatonin can suppress cytotoxicity caused by CP with its antioxidant properties. Melatonin also reduces TD50 of CP for HepG2 cell lines. © 2006 Edward Arnold (Publishers) Ltd. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Human and Experimental Toxicology | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Antioxidant | en_US |
dc.subject | Chlorpyrifos | en_US |
dc.subject | Free radical | en_US |
dc.subject | HepG2 | en_US |
dc.subject | Melatonin | en_US |
dc.subject | catalase | en_US |
dc.subject | chlorpyrifos | en_US |
dc.subject | glutathione peroxidase | en_US |
dc.subject | melatonin | en_US |
dc.subject | superoxide dismutase | en_US |
dc.subject | thiobarbituric acid reactive substance | en_US |
dc.subject | antioxidant activity | en_US |
dc.subject | article | en_US |
dc.subject | cell protection | en_US |
dc.subject | cell strain HepG2 | en_US |
dc.subject | cell viability | en_US |
dc.subject | controlled study | en_US |
dc.subject | cytotoxicity | en_US |
dc.subject | dose response | en_US |
dc.subject | drug mechanism | en_US |
dc.subject | enzyme activity | en_US |
dc.subject | enzyme inhibition | en_US |
dc.subject | human | en_US |
dc.subject | human cell | en_US |
dc.subject | LD 50 | en_US |
dc.subject | oxidative stress | en_US |
dc.subject | priority journal | en_US |
dc.subject | Antioxidants | en_US |
dc.subject | Catalase | en_US |
dc.subject | Cell Line, Tumor | en_US |
dc.subject | Cell Survival | en_US |
dc.subject | Dose-Response Relationship, Drug | en_US |
dc.subject | Glutathione Peroxidase | en_US |
dc.subject | Humans | en_US |
dc.subject | Insecticides | en_US |
dc.subject | Superoxide Dismutase | en_US |
dc.subject | Thiobarbituric Acid Reactive Substances | en_US |
dc.title | Melatonin can suppress the cytotoxic effects of chlorpyrifos on human HepG2 cell lines | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 25 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.startpage | 47 | |
dc.identifier.startpage | 47 | en_US |
dc.identifier.endpage | 55 | en_US |
dc.authorid | 0000-0002-9477-8571 | - |
dc.identifier.doi | 10.1191/0960327106ht584oa | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.pmid | 16539209 | en_US |
dc.identifier.scopus | 2-s2.0-33644753934 | en_US |
dc.identifier.wos | WOS:000236012100001 | en_US |
dc.identifier.scopusquality | Q2 | - |
dc.owner | Pamukkale_University | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.languageiso639-1 | en | - |
item.grantfulltext | none | - |
item.openairetype | Article | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
17
checked on Nov 16, 2024
WEB OF SCIENCETM
Citations
11
checked on Nov 21, 2024
Page view(s)
50
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.